Rat IgG2b isotype control-InVivo

目录号：A2116         批次号: A211615

       克隆号：LTF-2

打印

Rat IgG2b isotype control-InVivo 单克隆抗体（克隆号：LTF-2）可与锁孔血蓝蛋白 (keyhole limpet hemocyanin, KLH) 发生反应。由于哺乳动物不表达 KLH，因此该抗体非常适合在大多数体内和体外应用中用作大鼠 IgG2b 抗体的同种型匹配对照。

抗体信息

克隆号 LTF-2
配制 PBS Buffer, PH 7.4
推荐同型对照 Rat IgG2b, κ
来源 CHO
储存条件
(自收到货起)		 Store the undiluted solution at 4°C in the dark to avoid freeze-thaw cycles
除菌 0.2 μM filtered
纯度 99%
蛋白浓度 7.54 mg/mL
内毒素 ＜1 EU/mg

客户使用selleck产品的实验数据

Rat IgG2b isotype control-InVivo在文献中得到引用

Metabolic landscape of head and neck squamous cell carcinoma informs a novel kynurenine/Siglec-15 axis in immune escape [ Cancer Commun (Lond), 2024, 10.1002/cac2.12545] PubMed: 38734931
Metabolic landscape of head and neck squamous cell carcinoma informs a novel kynurenine/Siglec-15 axis in immune escape [ Cancer Commun (Lond), 2024, 44(6):670-694] PubMed: 38734931
Targeting the HSP47-collagen axis inhibits brain metastasis by reversing M2 microglial polarization and restoring anti-tumor immunity [ Cell Rep Med, 2024, 5(5):101533] PubMed: 38744278
Low-inflammatory lipid nanoparticle-based mRNA vaccine elicits protective immunity against H5N1 high-pathogenicity avian influenza virus with reduced adverse reactions [ Mol Ther, 2024, S1525-0016(24)00831-1] PubMed: 39690742
Deubiquitinase USP4 suppresses antitumor immunity by inhibiting IRF3 activation and tumor cell-intrinsic interferon response in colorectal cancer [ Cancer Lett, 2024, 589:216836.] PubMed: 38556105
Low-dose radiotherapy combined with dual PD-L1 and VEGFA blockade elicits antitumor response in hepatocellular carcinoma mediated by activated intratumoral CD8+ exhausted-like T cells [ Nat Commun, 2023, 14(1):7709.] PubMed: 38001101
Low-dose radiotherapy combined with dual PD-L1 and VEGFA blockade elicits antitumor response in hepatocellular carcinoma mediated by activated intratumoral CD8+ exhausted-like T cells [ Nat Commun, 2023, 14(1):7709] PubMed: 38001101
Oncolytic virus M1 functions as a bifunctional checkpoint inhibitor to enhance the antitumor activity of DC vaccine [ Cell Rep Med, 2023, 4(10):101229] PubMed: 37820722
Oncolytic virus M1 functions as a bifunctional checkpoint inhibitor to enhance the antitumor activity of DC vaccine [ Cell Rep Med, 2023, 4(10):101229] PubMed: 37820722
Oncolytic virus M1 functions as a bifunctional checkpoint inhibitor to enhance the antitumor activity of DC vaccine [ Cell Rep Med, 2023, 4:101229.] PubMed: 37820722

禁止用于人体及治疗！